Nasonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in adults and children as directed by a healthcare professional.

GNH USA supplies Nasonex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasonex, a nasal corticosteroid, is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. Nasal polyps: decreases polyp size and improves nasal airflow.

Nasonex may cause a range of adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation

Serious or Rare Side Effects: - Nasal septal perforation - Vision changes such as blurred vision - Severe allergic reaction (anaphylaxis)

Before using Nasonex, consider the following precautions. - Pregnancy: consult a healthcare provider as safety has not been fully established. - Pediatric use: use only as prescribed; safety established for children aged 2 years and older. - Active infections: monitor for fungal or bacterial infections of the nasal passages. - Concomitant systemic corticosteroids: avoid excessive cumulative corticosteroid exposure. - Store at room temperature: keep in the original packaging, protect from moisture and heat, and do not freeze.

Nasonex can interact with other medicines; review the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase systemic exposure to mometasone. - Systemic immunosuppressants: additive risk of immunosuppression.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may modestly raise mometasone levels. - Ritonavir: may increase exposure. - Live vaccines: reduced efficacy when used concurrently.